Medication Addition to Existing Regimen

Symptom-Specific Medication Additions

• The American College of Obstetricians and Gynecologists recommends considering a stimulant medication, such as methylphenidate or amphetamine, for residual ADHD symptoms in patients already on Qelbree, with careful monitoring for irritability, insomnia, feeding difficulty, and cardiovascular effects 1
• Stimulants show larger effect sizes than non-stimulants for ADHD core symptoms, according to the American Society for Clinical Psychopharmacology 2
• Non-pharmacological interventions, such as cognitive-behavioral therapy (CBT) or dialectical behavior therapy (DBT), should be considered as first-line treatments for residual anxiety in patients on SSRIs, as suggested by the American College of Obstetricians and Gynecologists 1

Monitoring Requirements for Current Regimen

• The American Academy of Pediatrics recommends administering Qelbree in the morning for optimal ADHD symptom control throughout the day, with therapeutic effects potentially not observed until 2-4 weeks after initiation 3